CDX Select
CDX Model Bank
Streamline CDX model selection with powerful filters for tumor indication and genetic profile.
79 cell lines
page 4 of 4
SW480
Colorectal
Dukes' type B, Colorectal Adenocarcinoma
Mutated genes
APC
ATM
KRAS
TP53
Lumin data
✓ Proteomics: available
✓ RNA-Seq: available
✓ WES: available
View cell line →
SW620
Colorectal
Dukes' type C, Colorectal Adenocarcinoma
Mutated genes
APC
KRAS
TP53
Lumin data
– Proteomics: not available
– RNA-Seq: not available
– WES: not available
View cell line →
THP-1
Leukemia
Acute Monocytic Leukemia (AML)
Mutated genes
NRAS
TP53
Lumin data
– Proteomics: not available
✓ RNA-Seq: available
✓ WES: available
View cell line →
U-87 MG
Glioblastoma
Glioblastoma
Mutated genes
ATRX
NF1
TERT
Lumin data
– Proteomics: not available
– RNA-Seq: not available
– WES: not available
View cell line →
UM-UC-14
Kidney
Transitional Cell Carcinoma
Mutated genes
FGFR3
PIK3CA
TP53
Lumin data
– Proteomics: not available
– RNA-Seq: not available
– WES: not available
View cell line →
VCaP
Prostate
Prostate carcinoma
Mutated genes
MSH6
TP53
Lumin data
✓ Proteomics: available
– RNA-Seq: not available
– WES: not available
View cell line →
ZR-75-1
Breast
Mutated genes
No gene data yet
Lumin data
✓ Proteomics: available
✓ RNA-Seq: available
✓ WES: available
View cell line →
Let's build the right study, together.
Backed by deep expertise in these models, our team will work with you to design the study around your target, line of therapy, and endpoint.